| | |||||
| lung cancer | |||||
| 新闻 | |||||
| Median Technologies Reports Landmark 2025 Performance With Major Regulatory ... - Morningstar The U.S., where lung cancer screening is already established with 14.5 million eligible patients, is our primary commercial target. We are ...
| |||||
| 查看更多结果 | 修改此快讯 | |||||
| 您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
| 发送反馈 |
No comments:
Post a Comment